MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, XOMAP made $52,149K in revenue. $31,712K in net income. Net profit margin of 60.81%.

Income Overview

Revenue
$52,149K
Net Income
$31,712K
Net Profit Margin
60.81%
EPS
$1.46
Unit: Thousand (K) dollars
Revenue Breakdown
    • Affitech Research As-Vabysmo
    • Tovorafenib-Viracta Therapeutics...
    • Revenue from contracts with cust...
    • Others
Revenue Breakdown
    • CH
    • US
    • Asia Pacific
    • AU

Income Statement
2025-12-31
Total income and revenues
52,149
Research and development
1,712
General and administrative
36,092
Amortization of intangible assets
2,961
Total operating expenses
40,765
Income (loss) from operations
11,384
Gains on acquisitions
21,224
Interest expense
13,031
Other income, net
12,238
Net income (loss) before tax
31,815
U.s. federal statutory tax rate
6,681
Foreign tax effects
103
Changes in valuation allowances
-2,538
Stock based compensation
-584
Nondeductible executive compensation
735
Bargain purchase gain
4,457
Other permanent differences
163
Income tax (expense) benefit
103
Net income (loss)
31,712
Basic EPS
1.53
Diluted EPS
1.46
Basic Average Shares
12,081,000
Diluted Average Shares
17,982,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Affitech ResearchAs-Vabysmo$23,957K Ladrx-Miplyffa$1,799K Aptevo-Ixinity$989K Tovorafenib-Viracta TherapeuticsInc.$13,716K Dsuvia-Talphera$28K Income from purchasedreceivables under the eir...$26,745K Income from purchasedreceivables under the cost...$13,744K Revenue from contractswith customers$10,350K Revenue recognizedunder...$1,310K Total income andrevenues$52,149K Gains on acquisitions$21,224K Other income, net$12,238K Income (loss) fromoperations$11,384K Total operatingexpenses$40,765K Net income (loss)before tax$31,815K Interest expense$13,031K General andadministrative$36,092K Amortization of intangibleassets$2,961K Research and development$1,712K Net income (loss)$31,712K Income tax (expense)benefit$103K Bargain purchase gain$4,457K Changes in valuationallowances-$2,538K Stock basedcompensation-$584K U.s. federalstatutory tax rate$6,681K Nondeductible executivecompensation$735K Other permanentdifferences$163K Foreign tax effects$103K

XOMA Royalty Corp (XOMAP)

XOMA Royalty Corp (XOMAP)